NEO
Price
$6.20
Change
-$0.04 (-0.64%)
Updated
Jul 21, 04:59 PM (EDT)
Capitalization
2.01B
8 days until earnings call
RGEN
Price
$114.75
Change
-$1.50 (-1.29%)
Updated
Jul 21, 04:59 PM (EDT)
Capitalization
10.26B
8 days until earnings call
Interact to see
Advertisement

NEO vs RGEN

Header iconNEO vs RGEN Comparison
Open Charts NEO vs RGENBanner chart's image
NeoGenomics
Price$6.20
Change-$0.04 (-0.64%)
Volume$52.13K
Capitalization2.01B
Repligen
Price$114.75
Change-$1.50 (-1.29%)
Volume$26.35K
Capitalization10.26B
NEO vs RGEN Comparison Chart in %
Loading...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEO vs. RGEN commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEO is a Hold and RGEN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (NEO: $6.24 vs. RGEN: $116.25)
Brand notoriety: NEO and RGEN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NEO: 105% vs. RGEN: 145%
Market capitalization -- NEO: $2.01B vs. RGEN: $10.26B
NEO [@Medical Specialties] is valued at $2.01B. RGEN’s [@Medical Specialties] market capitalization is $10.26B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEO’s FA Score shows that 0 FA rating(s) are green whileRGEN’s FA Score has 1 green FA rating(s).

  • NEO’s FA Score: 0 green, 5 red.
  • RGEN’s FA Score: 1 green, 4 red.
According to our system of comparison, RGEN is a better buy in the long-term than NEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEO’s TA Score shows that 4 TA indicator(s) are bullish while RGEN’s TA Score has 2 bullish TA indicator(s).

  • NEO’s TA Score: 4 bullish, 5 bearish.
  • RGEN’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, NEO is a better buy in the short-term than RGEN.

Price Growth

NEO (@Medical Specialties) experienced а -14.05% price change this week, while RGEN (@Medical Specialties) price change was -13.25% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.54%. For the same industry, the average monthly price growth was +3.32%, and the average quarterly price growth was -2.57%.

Reported Earning Dates

NEO is expected to report earnings on Jul 29, 2025.

RGEN is expected to report earnings on Jul 29, 2025.

Industries' Descriptions

@Medical Specialties (+0.54% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGEN($10.3B) has a higher market cap than NEO($2.01B). RGEN has higher P/E ratio than NEO: RGEN (247.52) vs NEO (49.50). RGEN YTD gains are higher at: -19.237 vs. NEO (-62.136). RGEN has higher annual earnings (EBITDA): 134M vs. NEO (-17.61M). RGEN has more cash in the bank: 751M vs. NEO (415M). NEO has less debt than RGEN: NEO (612M) vs RGEN (712M). RGEN has higher revenues than NEO: RGEN (639M) vs NEO (592M).
NEORGENNEO / RGEN
Capitalization2.01B10.3B19%
EBITDA-17.61M134M-13%
Gain YTD-62.136-19.237323%
P/E Ratio49.50247.5220%
Revenue592M639M93%
Total Cash415M751M55%
Total Debt612M712M86%
FUNDAMENTALS RATINGS
NEO vs RGEN: Fundamental Ratings
NEO
RGEN
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
10099
SMR RATING
1..100
9390
PRICE GROWTH RATING
1..100
9381
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEO's Valuation (73) in the Medical Or Nursing Services industry is in the same range as RGEN (95) in the Biotechnology industry. This means that NEO’s stock grew similarly to RGEN’s over the last 12 months.

RGEN's Profit vs Risk Rating (99) in the Biotechnology industry is in the same range as NEO (100) in the Medical Or Nursing Services industry. This means that RGEN’s stock grew similarly to NEO’s over the last 12 months.

RGEN's SMR Rating (90) in the Biotechnology industry is in the same range as NEO (93) in the Medical Or Nursing Services industry. This means that RGEN’s stock grew similarly to NEO’s over the last 12 months.

RGEN's Price Growth Rating (81) in the Biotechnology industry is in the same range as NEO (93) in the Medical Or Nursing Services industry. This means that RGEN’s stock grew similarly to NEO’s over the last 12 months.

RGEN's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for NEO (100) in the Medical Or Nursing Services industry. This means that RGEN’s stock grew significantly faster than NEO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NEORGEN
RSI
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 11 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
72%
MACD
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 13 days ago
77%
Bullish Trend 5 days ago
74%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 7 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
84%
Aroon
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 6 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OTCGX23.040.10
+0.44%
MFS Mid Cap Growth R1
MADFX35.710.04
+0.11%
Matrix Advisors Dividend
FSBCX20.780.01
+0.05%
Federated Hermes Global Allocation C
CSVZX38.01N/A
N/A
Columbia Select Large Cap Value Inst
VMMSX25.04-0.02
-0.08%
Vanguard Emerg Mkts Sel Stk Inv

NEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEO has been loosely correlated with RGEN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NEO jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEO
1D Price
Change %
NEO100%
-7.14%
RGEN - NEO
43%
Loosely correlated
-6.28%
FLGT - NEO
40%
Loosely correlated
-1.93%
VCYT - NEO
36%
Loosely correlated
-2.93%
NNOX - NEO
36%
Loosely correlated
+1.38%
BLFS - NEO
36%
Loosely correlated
-2.75%
More

RGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGEN has been closely correlated with DHR. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if RGEN jumps, then DHR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGEN
1D Price
Change %
RGEN100%
-6.28%
DHR - RGEN
67%
Closely correlated
-2.43%
A - RGEN
67%
Closely correlated
-2.04%
BIO - RGEN
64%
Loosely correlated
-1.30%
TMO - RGEN
61%
Loosely correlated
-2.41%
BRKR - RGEN
60%
Loosely correlated
-3.89%
More